BANK VONTOBEL/PUT/INTUITIVE SURGICAL/300/0.1/20.12.24 Stock

Warrant

DE000VD3LR24

Market Closed - Bid/Ask 14:06:23 2024-07-01 EDT After market 15:05:28
0.22 EUR +14.58% Intraday chart for BANK VONTOBEL/PUT/INTUITIVE SURGICAL/300/0.1/20.12.24 0.235 +6.82%
Current month+14.58%
1 month-57.69%
Date Price Change
24-07-01 0.22 +14.58%
24-06-28 0.192 -4.48%
24-06-27 0.201 +6.35%
24-06-26 0.189 -1.05%
24-06-25 0.191 -11.98%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 02:06 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3LR2
ISINDE000VD3LR24
Date issued 2024-04-05
Strike 300 $
Maturity 2024-12-20 (172 Days)
Parity 10 : 1
Emission price 0.97
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.22
Lowest since issue 0.182
Delta-0.05x
Omega 8.370
Premium31.67x
Gearing172.75x
Moneyness 0.6891
Difference Strike -136.3 $
Difference Strike %-45.44%
Spread 0.03
Spread %12.00%
Theoretical value 0.2350
Implied Volatility 37.90 %
Total Loss Probability 91.93 %
Intrinsic value 0.000000
Present value 0.2350
Break even 297.48 €
Theta-0.02x
Vega0.03x
Rho-0.01x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
444.8 USD
Average target price
426.5 USD
Spread / Average Target
-4.13%
Consensus